Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
Eva Ramos, Francisco López‐Muñoz, Emilio Gil‐Martín, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1152-1152
Open Access | Times Cited: 24

Showing 24 citing articles:

CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
Tapan Behl, Ishnoor Kaur, Lotfi Aleya, et al.
The Science of The Total Environment (2021) Vol. 808, pp. 152072-152072
Open Access | Times Cited: 96
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
Mihaela Stoia, Simona Oancea
Antioxidants (2022) Vol. 11, Iss. 4, pp. 638-638
Open Access | Times Cited: 48
Melatonin and Related Compounds: Antioxidant and Anti-Inflammatory Actions
Maria Anna Bantounou, Josip Plascevic, Helen F. Galley
Antioxidants (2022) Vol. 11, Iss. 3, pp. 532-532
Open Access | Times Cited: 42
Possible Role of Pineal and Extra-Pineal Melatonin in Surveillance, Immunity, and First-Line Defense
Regina P. Markus, Kassiano dos Santos Sousa, Sanseray da Silveira Cruz‐Machado, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12143-12143
Open Access | Times Cited: 44
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Russel J. Reıter, Ramaswamy Sharma, Fedor Šimko, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 35
Efficacy of melatonin in the treatment of patients with COVID‐19: A systematic review and meta‐analysis of randomized controlled trials
Shao‐Huan Lan, Hong‐Zin Lee, Chien‐Ming Chao, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 2102-2107
Open Access | Times Cited: 34
Sleep Deprivation, Immune Suppression and SARS-CoV-2 Infection
Beatrice Ragnoli, Patrizia Pochetti, Patrizia Pignatti, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 2, pp. 904-904
Open Access | Times Cited: 29
Impact of COVID‐19 pandemic on sleep of undergraduate students: A systematic literature review
Rafael Lorenzo G Valenzuela, Raphael Ian B. Velasco, Manuel Peter Paul C. Jorge
Stress and Health (2022) Vol. 39, Iss. 1, pp. 4-34
Open Access | Times Cited: 25
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 23
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging
Victoria Jiménez, Eva Ramos, Pedro Segura‐Chama, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1844-1844
Open Access | Times Cited: 14
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Russel J. Reıter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Redox Homeostasis Alteration Is Restored through Melatonin Treatment in COVID-19 Patients: A Preliminary Study
Marí­a Elena Soto, Israel Pérez-Torres, Linaloe Manzano-Pech, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4543-4543
Open Access | Times Cited: 5
The Redox Homeostasis Alteration Is Restored by Melatonin Treatment in COVID-19 Patients
Marí­a Elena Soto, Israel Pérez-Torres, Linaloe Manzano-Pech, et al.
(2024)
Open Access | Times Cited: 3
Mitochondria in COVID-19: from cellular and molecular perspective
Michał Rurek
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 2
Hospitalized COVID-19 Patients Were Five Times More Likely to Suffer From Total Sleep Deprivation Compared to Non-COVID-19 Patients; an Observational Comparative Study
Eva S. van den Ende, Kim D. I. van Veldhuizen, Belle Toussaint, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 16
A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19
Wen‐Lin Su, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
Can melatonin reduce the severity of post-COVID-19 syndrome?
Amine Souissi, Ismail Dergaa, Mohamed Romdhani, et al.
PubMed (2023) Vol. 22, pp. 173-187
Closed Access | Times Cited: 6
Efficacy, Safety, and Drug–Drug Interactions for Insomnia Therapy in COVID-19 Patients
Billy Dwi Saputra, Jutti Levita, Resmi Mustarichie
Journal of Multidisciplinary Healthcare (2022) Vol. Volume 15, pp. 137-152
Open Access | Times Cited: 7
Schlafstörungen und Erschöpfungssyndrom bei Long-COVID-Syndrom: Fallbasierte Erfahrungen aus der neurologischen/schlafmedizinischen Rehabilitation
P. Young
Somnologie - Schlafforschung und Schlafmedizin (2022) Vol. 26, Iss. 2, pp. 73-79
Open Access | Times Cited: 6
SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease
Yuhai Zhao, Walter J. Lukiw
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 6
Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview
Anna Gorący, Jakub Rosik, Bartosz Szostak, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1092-1092
Open Access | Times Cited: 5
Melatonin and Covid-19: An opened Pandora's box and the hope for the time being
Leonor Chacín‐Bonilla, Ernesto Bonilla
Melatonin Research (2023) Vol. 6, Iss. 4, pp. 474-484
Open Access | Times Cited: 1
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Page 1

Scroll to top